Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12413198 | 0.97 | BCL2L1 (0.35) | BCL2L1MCL1 | |
| SCHEMBL12413369 | 0.92 | BCL2L1 (0.32) | BCL2L1MCL1 | |
| SCHEMBL12504634 | 0.91 | NPC1 (0.30) | — | |
| SCHEMBL12504759 | 0.88 | NPC1 (0.32) | BCL2L1MCL1 | |
| SCHEMBL12413307 | 0.88 | BCL2L1 (0.36) | BCL2L1MCL1 | |
| SCHEMBL12413308 | 0.88 | BCL2L1 (0.36) | BCL2L1MCL1 | |
| SCHEMBL12413212 | 0.85 | BCL2L1 (0.33) | BCL2L1MCL1 | |
| SCHEMBL12413194 | 0.84 | BCL2L1 (0.38) | BCL2L1MCL1 | |
| SCHEMBL12413196 | 0.84 | BCL2L1 (0.38) | BCL2L1MCL1 | |
| SCHEMBL12413208 | 0.81 | BCL2L1 (0.38) | BCL2L1MCL1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20110166362-A1 | NOVEL COMPOUND AND ORGANIC SEMICONDUCTOR MATERIAL | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2011-07-07 | — | — | US | disclosed |
| US-20110166362-A1 | NOVEL COMPOUND AND ORGANIC SEMICONDUCTOR MATERIAL | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2011-07-07 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110166362-A1 | NOVEL COMPOUND AND ORGANIC SEMICONDUCTOR MATERIAL | SCLY, MSRB3, SOD1 | BCL2L1 2064/4885MCL1 4068/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.